What is the main business of Sancoll Medicall?

The main business activity of Sancoll Medicall focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 28, 2016.

Where is the headquarters located?

The headquarters is located at: ul. Wakacyjna 17, 35-317 Rzeszów.

Who is on the management board?

The management board consists of: Paweł Radosław Zacharski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

How much revenue was generated?

In 2022, the company generated total revenue of $37,564, representing an increase of 222.0% compared to 2021.

Is the company profitable?

Yes, the company recorded a net profit of $547 in 2022, meaning the company increased its profit by 125.3%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $27,280 in 2022, representing 74% of all operating expenses.

Sancoll Medicallsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-12-28

Share capital

5,000.00 PLN

Registered address

ul. Wakacyjna 17, 35-317 Rzeszów, Poland

Website

sancoll.pl

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 4 of 5 financial statements were filed late (the longest delay 817 days for 2018).

2023not filed
202208/08/2024
202114/10/2022
202009/10/2021
201920/10/2021
201809/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.

Industry · Manufacture of pharmaceutical preparations205 / 258

Top 79%

Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations254 / 330

Top 77%

Sector · Manufacturing27,641 / 33,744

Top 82%

Voivodeship · Podkarpackie11,591 / 16,360

Top 71%

Country · Poland346,621 / 495,860

Top 70%

Results vs industry

Revenue

This companyUSD 37.56kMedianUSD 919.05kAverageUSD 25.83m

Net profit

This companyUSD 547.17MedianUSD 14.92kAverageUSD 2.77m

Operating costs

This companyUSD 36.96kMedianUSD 873.06kAverageUSD 21.43m

Assets

This companyUSD 43.23kMedianUSD 897.46kAverageUSD 31.52m

Industry

Authorized Representatives

Wiktor Mariusz Superson – Attorney-in-fact

Paweł Radosław Zacharski – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Andrzej Kazimierz Argalskiage 69	50	$675.31	50%
Joanna Magda Zacharskaage 50	46	$621.29	46%
Others	4	$54.02	4%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2018-05-12 to 2026-08-11.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
May 16, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	STAROSTA POWIATU RZESZÓW

Competitors

Name	Revenue	Website
ICN Polfa RzeszówS.A.	$85,044,250.03	icnpolfa.pl
Ti-Comsp. z o.o.	$157,549.77	ticomglobal.com
LideoS.A.	$95,067.91	lideo.tech
Munar PharmaS.A.	$85,649.72	munar.pl
BIO Animalisp. z o.o.	$49,176.96	proanimali.com
Ampliconsp. z o.o.	$48,330.99	amplicon.pl
Xenira Pharmaceuticalssp. z o.o.	$26,670.82	xenirapharma.com
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com

Change history

Date	Event
2021-03-12	Name change (Tars Consulting → Sancoll Medicall)
2021-03-12	PKD change (Removed: 5 codes; Added: 5 codes)
2016-12-28	Entered in the register

FAQ

Last updated: 2026-04-21